Gland Pharma Ltd. (GLAND) - Financials, balance sheet (quarterly)

1,460.30005 INR

0.8999

0.06%

Last update May 15, 3:29 PM IST

Market closed

Day range

1,460.30005

1,457.099976

1,473

Previous close

1,461.19995

Open

1,468

Access this stock data via API

Gland Pharma Ltd.

1,460.30

0.90

0.06%

Financials

Balance sheet

Fiscal date	Sep 2024	Mar 2024	Sep 2023	Mar 2023
Total assets	108.7B	106.6B	102.9B	87.8B
Current assets	64.0B	56.5B	59.7B	69.0B
Cash	—	3.6B	—	19.1B
Cash equivalents	—	—	—	13.6B
Cash and cash equivalents	28.2B	3.6B	4.8B	19.1B
Other short term investments	1.1B	15.8B	17.3B	18.5B
Accounts receivable	14.9B	15.6B	13.7B	8.7B
Other receivables	—	1.5B	243.8M	1.6B
Inventory	15.8B	16.6B	20.8B	19.5B
Prepaid assets	—	2.4B	—	1.5B
Restricted cash	—	1.0B	—	78.5M
Assets held for sale	—	—	—	—
Hedging assets	—	—	—	—
Other current assets	4.1B	3.4B	2.8B	2.5B
Non current assets	44.6B	50.2B	43.2B	18.8B
Properties	36.6B	3.3B	30.9B	2.1B
Land and improvements	—	9.3B	—	646.0M
Machinery furniture equipment	—	27.8B	—	16.8B
Construction in progress	2.8B	2.8B	3.2B	2.4B
Leases	—	—	—	—
Accumulated depreciation	—	-10.4B	—	-7.2B
Goodwill	6.2B	6.0B	10.7B	116.6M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	1.1B	1.1B	1.5B	116.6M
Investments and advances	—	—	—	—
Other non current assets	845.5M	976.2M	977.8M	1.1B
Total liabilities	20.8B	19.4B	19.9B	8.2B
Current liabilities	15.4B	14.0B	15.4B	7.3B
Accounts payable	10.0B	8.6B	9.8B	5.9B
Accrued expenses	—	—	—	—
Short term debt	2.0B	2.3B	2.1B	7.1M
Deferred revenue	—	—	—	—
Tax payable	1.0B	516.4M	614.9M	9.9M
Pensions	—	589.1M	—	313.2M
Other current liabilities	1.7B	3.9M	2.4B	35.8M
Non current liabilities	5.4B	5.4B	4.5B	896.8M
Long term provisions	1.5B	1.4B	1.2B	17.3M
Long term debt	1.3B	1.4B	1.5B	37.4M
Provision for risks and charges	—	—	—	—
Deferred liabilities	2.2B	2.2B	1.3B	842.0M
Derivative product liabilities	—	—	—	—
Other non current liabilities	461.3M	404.9M	437.5M	—
Shareholders equity
Common stock	164.8M	164.7M	164.7M	164.7M
Retained earnings	—	67.9B	—	60.2B
Other shareholders equity	—	—	—	—
Total shareholders equity	87.9B	87.2B	83.1B	79.6B
Additional paid in capital	—	19.3B	—	19.3B
Treasury stock	—	—	—	—
Minority interest	0	0	0	0